echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The Safety of 2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine

    The Safety of 2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine

    • Last Update: 2023-05-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine is a heterocyclic compound that is commonly used in the chemical industry.
    It is known for its unique structural properties and versatile applications.
    In this article, we will discuss the safety of 2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine.


    2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine is a synthetic compound that is used as a building block for the synthesis of other chemicals.
    It is typically used in the production of agrochemicals, pharmaceuticals, and other specialty chemicals.
    Due to its widespread use in the chemical industry, it is important to examine its safety.


    2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine is classified as a moderately toxic compound.
    It has a moderate potential for skin irritation, and it is slightly toxic if ingested, inhaled or if it comes in contact with the eyes.
    However, it is not classified as a highly toxic compound, and it is considered safe to handle if appropriate precautions are taken.


    When handling 2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine, it is important to wear appropriate protective equipment, such as gloves, a face mask, and safety glasses.
    Additionally, it is important to store the compound in a cool, dry, and well-ventilated area, away from any sources of ignition or heat.


    Inhalation:


    2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine is not heavily absorbed through the skin, but it can cause respiratory irritation if inhaled.
    Prolonged exposure to the compound can lead to respiratory problems, such as coughing, wheezing, and shortness of breath.


    Ingestion:


    2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine is slightly toxic if ingested.
    It can cause gastrointestinal disturbances, such as nausea, vomiting, and diarrhea.
    However, it is not expected to cause severe poisoning if ingested in small amounts.


    Skin Contact:


    2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine is not heavily absorbed through the skin, but it can cause skin irritation.
    Prolonged exposure to the compound can lead to skin problems, such as redness, itching, and blistering.


    Eye Contact:


    2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine is not heavily absorbed through the skin, but it can cause eye irritation if it comes in contact with the eyes.
    Prolonged exposure to the compound can lead to eye problems, such as redness, itching, and tearing.


    Handling:


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.